BR100 Increased By (1.58%)
BR30 Increased By (1.71%)
KSE100 Increased By (1.59%)
KSE30 Increased By (1.64%)
BECO 5.75 Increased By ▲ 0.04 (0.7%)
BML 59.94 Increased By ▲ 0.27 (0.45%)
BOP 36.53 Increased By ▲ 0.80 (2.24%)
CNERGY 8.40 Increased By ▲ 0.12 (1.45%)
DCL 12.14 Increased By ▲ 0.01 (0.08%)
FCCL 57.66 Increased By ▲ 0.27 (0.47%)
FCSC 5.46 Decreased By ▼ -0.06 (-1.09%)
FFL 18.14 Increased By ▲ 0.11 (0.61%)
FNEL 1.37 Increased By ▲ 0.02 (1.48%)
HUMNL 11.75 Increased By ▲ 0.09 (0.77%)
KEL 8.22 Increased By ▲ 0.15 (1.86%)
KOSM 6.32 Increased By ▲ 0.06 (0.96%)
MLCF 98.80 Increased By ▲ 0.67 (0.68%)
NBP 205.15 Increased By ▲ 6.82 (3.44%)
PACE 11.84 Increased By ▲ 0.07 (0.59%)
PAEL 44.29 Increased By ▲ 1.20 (2.78%)
PIAHCLA 27.77 Increased By ▲ 0.42 (1.54%)
PIBTL 18.00 Increased By ▲ 0.04 (0.22%)
PPL 234.00 Increased By ▲ 1.22 (0.52%)
PRL 36.34 Increased By ▲ 0.65 (1.82%)
PTC 68.05 Increased By ▲ 0.47 (0.7%)
SEARL 95.68 Increased By ▲ 1.40 (1.48%)
SSGC 30.15 Increased By ▲ 2.49 (9%)
TELE 9.25 Increased By ▲ 0.06 (0.65%)
THCCL 70.40 Decreased By ▼ -0.19 (-0.27%)
TPLP 11.41 Increased By ▲ 0.04 (0.35%)
TREET 25.81 Increased By ▲ 0.39 (1.53%)
TRG 69.40 Increased By ▲ 0.55 (0.8%)
WAVES 11.55 Increased By ▲ 0.30 (2.67%)
WTL 1.31 Increased By ▲ 0.02 (1.55%)
By

Britain’s FTSE 100 hit a record high on Thursday as miner Anglo American surged on a buyout offer from BHP Group, while investors cheered earnings from several blue-chip firms including Unilever, AstraZeneca and Barclays.

Shares of Anglo American surged 12.7% to a nine-month high after BHP said it made an offer to buy the London-listed miner, valuing its share capital at 31.1 billion pounds ($38.84 billion).

The deal would create the world’s biggest copper miner with around 10% of global output. BHP’s UK-listed stock fell 3.7%.

The FTSE 350 industrial metal miners index rose 2.6%, while the blue-chip FTSE 100 ticked up 0.7% to a record high of 8,098.14. The mid-cap FTSE 250 was down 0.5%.

FTSE 100 extends record run on earnings optimism

AstraZeneca gained 5.3% after the drugmaker reported quarterly revenue and profit above market estimates buoyed by resilient demand for its oncology and rare blood disorder drugs.

Unilever rose 4.1% after the consumer goods company reported first-quarter sales that grew by a better than expected 4.4%, as it won back shoppers who had traded down to cheaper products.

Barclays climbed 3.1% despite reporting a 12% fall in first-quarter profit.

Comments

Comments are closed for this article.